title: Waldenström macroglobulinaemia and intestinal lymphangiectasia.
authors.affiliation: Department of Haematology, Austin Health, Melbourne, Australia.
authors.forename: Rachel E
authors.initials: RE
authors.lastname: Cooke
authors.forename: Renate M
authors.initials: RM
authors.lastname: Kalnins
authors.forename: Wai Khoon
authors.initials: WK
authors.lastname: Ho
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D003967:Diarrhea / Q000209:etiology; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D007145:Immunoglobulin kappa-Chains / Q000097:blood*; D016130:Immunophenotyping; D008201:Lymphangiectasis, Intestinal / Q000000981:diagnostic imaging / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010266:Paraproteins / Q000032:analysis*; D011239:Prednisolone / Q000008:administration & dosage; D011859:Radiography; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage; D008258:Waldenstrom Macroglobulinemia / Q000097:blood / Q000150:complications* / Q000188:drug therapy
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007075:Immunoglobulin M; D007145:Immunoglobulin kappa-Chains; D010266:Paraproteins; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone